T K Omsland1, J H Magnus. 1. Institute of Health and Society, University of Oslo, Oslo, Norway, t.k.omsland@medisin.uio.no.
Abstract
SUMMARY: A growing elderly population is expected worldwide, and the rate of hip fractures is decisive for the future fracture burden. Significant declines in hip fracture rates in Norway, the USA, France, Germany, and the UK are required to counteract the impact of the ageing effects. INTRODUCTION: This study aims to evaluate the consequences of the expected growth of the elderly population worldwide on the hip fracture burden using Norway as an example. Furthermore, we wanted to estimate the decline in hip fracture rates required to counteract the anticipated increase in the burden of hip fracture for Norway, the USA, France, Germany, and the UK. METHODS: The burden of future postmenopausal hip fractures in Norway were estimated given (1) constant age-specific rates, (2) continued decline, and (3) different cohort scenarios. Based on population projection estimates and population age-specific hip fracture rates in women 65 years and older, we calculated the required declines in hip fracture rates needed to counteract the growing elderly populations in Norway, the USA, France, Germany, and the UK. RESULTS: The level of age-specific hip fracture rates had a huge impact on the future hip fracture burden in Norway. Even if the hip fracture rates decline at the same speed, a 22 % increase in the burden of hip fractures can be expected by 2040. An annual decline in hip fracture rates of 1.1-2.2 % until 2040 is required to counteract the effects of the growing elderly population on the future burden of hip fractures in Norway, the USA, France, Germany, and the UK. CONCLUSIONS: Hip fracture rates have a great impact on the burden of hip fractures. The rates will have to decline significantly to counteract the impact of a growing elderly population. A change in preventive strategies and further studies are warranted to identify the complex causes associated to hip fractures.
SUMMARY: A growing elderly population is expected worldwide, and the rate of hip fractures is decisive for the future fracture burden. Significant declines in hip fracture rates in Norway, the USA, France, Germany, and the UK are required to counteract the impact of the ageing effects. INTRODUCTION: This study aims to evaluate the consequences of the expected growth of the elderly population worldwide on the hip fracture burden using Norway as an example. Furthermore, we wanted to estimate the decline in hip fracture rates required to counteract the anticipated increase in the burden of hip fracture for Norway, the USA, France, Germany, and the UK. METHODS: The burden of future postmenopausal hip fractures in Norway were estimated given (1) constant age-specific rates, (2) continued decline, and (3) different cohort scenarios. Based on population projection estimates and population age-specific hip fracture rates in women 65 years and older, we calculated the required declines in hip fracture rates needed to counteract the growing elderly populations in Norway, the USA, France, Germany, and the UK. RESULTS: The level of age-specific hip fracture rates had a huge impact on the future hip fracture burden in Norway. Even if the hip fracture rates decline at the same speed, a 22 % increase in the burden of hip fractures can be expected by 2040. An annual decline in hip fracture rates of 1.1-2.2 % until 2040 is required to counteract the effects of the growing elderly population on the future burden of hip fractures in Norway, the USA, France, Germany, and the UK. CONCLUSIONS:Hip fracture rates have a great impact on the burden of hip fractures. The rates will have to decline significantly to counteract the impact of a growing elderly population. A change in preventive strategies and further studies are warranted to identify the complex causes associated to hip fractures.
Authors: Björn E Rosengren; Henrik G Ahlborg; Dan Mellström; Jan-Åke Nilsson; Jonas Björk; Magnus K Karlsson Journal: Epidemiology Date: 2012-07 Impact factor: 4.822
Authors: Sonia Jean; Siobhan O'Donnell; Claudia Lagacé; Peter Walsh; Christina Bancej; Jacques P Brown; Suzanne Morin; Alexandra Papaioannou; Susan B Jaglal; William D Leslie Journal: J Bone Miner Res Date: 2013-06 Impact factor: 6.741
Authors: Tone K Omsland; Kristin Holvik; Haakon E Meyer; Jacqueline R Center; Nina Emaus; Grethe S Tell; Berit Schei; Aage Tverdal; Clara G Gjesdal; Guri Grimnes; Siri Forsmo; John A Eisman; Anne Johanne Søgaard Journal: Eur J Epidemiol Date: 2012-06-30 Impact factor: 8.082
Authors: C Cooper; Z A Cole; C R Holroyd; S C Earl; N C Harvey; E M Dennison; L J Melton; S R Cummings; J A Kanis Journal: Osteoporos Int Date: 2011-04-02 Impact factor: 4.507
Authors: Aline Gauthier; John A Kanis; Yling Jiang; Monique Martin; Juliet E Compston; Fredrik Borgström; Cyrus Cooper; Eugene V McCloskey Journal: Arch Osteoporos Date: 2011-07-26 Impact factor: 2.617
Authors: A Gauthier; J A Kanis; Y Jiang; K Dreinhöfer; M Martin; J Compston; F Borgström; C Cooper; E McCloskey Journal: Arch Osteoporos Date: 2012 Impact factor: 2.617
Authors: A J Søgaard; K Holvik; H E Meyer; G S Tell; C G Gjesdal; N Emaus; G Grimnes; B Schei; S Forsmo; T K Omsland Journal: Osteoporos Int Date: 2016-02-22 Impact factor: 4.507
Authors: J C Munson; J P W Bynum; J-E Bell; C McDonough; Q Wang; T Tosteson; A N A Tosteson Journal: Osteoporos Int Date: 2018-09-19 Impact factor: 4.507
Authors: Michael T Torchia; Jeffrey Munson; Tor D Tosteson; Anna N A Tosteson; Qianfei Wang; Christine M McDonough; Tamara S Morgan; Julie P W Bynum; John-Erik Bell Journal: J Am Med Dir Assoc Date: 2019-03 Impact factor: 4.669
Authors: A J Søgaard; J H Magnus; Å Bjørnerem; K Holvik; A H Ranhoff; N Emaus; H E Meyer; B H Strand Journal: Osteoporos Int Date: 2019-10-25 Impact factor: 4.507
Authors: Rong Ping Zhou; Si Jian Lin; Wen Bing Wan; Hui Ling Zuo; Fen Fen Yao; Hui Bing Ruan; Jin Xu; Wei Song; Yi Cheng Zhou; Shi Yao Wen; Jiang Hua Dai; Mei Lan Zhu; Jun Luo Journal: PLoS One Date: 2016-12-29 Impact factor: 3.240
Authors: Jeffrey C Munson; Julie P W Bynum; John-Erik Bell; Robert Cantu; Christine McDonough; Qianfei Wang; Tor D Tosteson; Anna N A Tosteson Journal: JAMA Intern Med Date: 2016-10-01 Impact factor: 21.873